Cresco Labs (CRLBF) Cash from Operations (2019 - 2025)
Cresco Labs' (CRLBF) quarterly Cash from Operations came in at 27432000.0 in Q4 2025, down 6.97% YoY from 29486000.0 in Q4 2024, and up 345.04% on a QoQ basis from 6164000.0 in Q3 2025.
Cresco Labs (CRLBF) Cash from Operations (2019 - 2025) Analysis & Trends
Cresco Labs (CRLBF) has 7 years of Cash from Operations data on file, last reported at 27432000.0 in Q4 2025.
- Quarterly Cash from Operations fell 6.97% year-over-year to 27432000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 112445000.0 (down 3.21% YoY) and the FY2025 annual result came in at 72890000.0, down 44.98% from the prior year.
- Cash from Operations grew to 27432000.0 in Q4 2025, from 6164000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 49363000.0 in Q3 2024 to a low of 43191000.0 in Q2 2021.
- A 5-year average of 16002787.16 and a median of 19277000.0 in 2021 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations tumbled 190.91% — and 2024, when it soared 993.24%.
- Tracing CRLBF's Cash from Operations over 5 years: stood at 37653000.0 in 2021, then plunged by 90.36% to 3631000.0 in 2022, then plunged by 190.91% to 3301000.0 in 2023, then soared by 993.24% to 29486000.0 in 2024, then decreased by 6.97% to 27432000.0 in 2025.
- The last three Cash from Operations figures came in at 27432000.0 (Q4 2025), 6164000.0 (Q3 2025), and 29486000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cresco Labs | 292.94 Mn | 228.83 Mn | 86.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.43 Mn |
| Dec 31, 2025 | 27.43 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Dec 31, 2024 | 29.49 Mn |
| Sep 30, 2024 | 49.36 Mn |
| Sep 30, 2024 | 49.36 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Dec 31, 2023 | -3.30 Mn |
| Sep 30, 2023 | 40.62 Mn |
| Sep 30, 2023 | 40.62 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Dec 31, 2022 | 3.63 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Sep 30, 2022 | 25.60 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Dec 31, 2021 | 37.65 Mn |
| Sep 30, 2021 | 5.62 Mn |
| Sep 30, 2021 | 5.62 Mn |